Recalls / Active ingredient / Dextroamphetamine
Dextroamphetamine
1 FDA drug recall involving the active ingredient “Dextroamphetamine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-10-31 | Class II | Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed tra | Noven Pharmaceuticals Inc |